Dechra Pharmaceuticals PLC
LSE:DPH

Watchlist Manager
Dechra Pharmaceuticals PLC Logo
Dechra Pharmaceuticals PLC
LSE:DPH
Watchlist
Price: 3 866 GBX Market Closed
Market Cap: 440.4B GBX
Have any thoughts about
Dechra Pharmaceuticals PLC?
Write Note

Wall Street
Price Targets

DPH Price Targets Summary
Dechra Pharmaceuticals PLC

There are no price targets for DPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Dechra Pharmaceuticals PLC Competitors:
Price Targets
VRNA
Verona Pharma PLC
6% Upside
CPH
Cipher Pharmaceuticals Inc
39% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
22% Upside
SDZ
Sandoz Group AG
13% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
29% Upside
INDOCO
Indoco Remedies Ltd
1% Downside
UCB
Ucb SA
2% Upside

Revenue
Forecast

Revenue Estimate
Dechra Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Dechra Pharmaceuticals PLC's revenue is 18%. The projected CAGR for the next 3 years is 9%.

18%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dechra Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Dechra Pharmaceuticals PLC's operating income is -1%. The projected CAGR for the next 3 years is 98%.

-1%
Past Growth
98%
Estimated Growth
Estimates Accuracy
-48%
Average Miss

Net Income
Forecast

Net Income Estimate
Dechra Pharmaceuticals PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DPH's stock price target?
Not Available

DPH doesn't have any price targets made by Wall Street professionals.

What is Dechra Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Dechra Pharmaceuticals PLC's revenue is 18%. The projected CAGR for the next 3 years is 9%.

What is Dechra Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
98%

For the last 8 years the compound annual growth rate for Dechra Pharmaceuticals PLC's operating income is -1%. The projected CAGR for the next 3 years is 98%.

Back to Top